242 related articles for article (PubMed ID: 18310651)
21. Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.
Fornai M; Colucci R; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):305-13. PubMed ID: 18853145
[TBL] [Abstract][Full Text] [Related]
22. Are proton pump inhibitors really superior to famotidine in Japanese ulcer patients?
Haruma K; Kamada T; Manabe N; Kusunoki H; Honda K; Inoue K; Shiotani A
Hepatogastroenterology; 2009; 56(93):1059-63. PubMed ID: 19760941
[TBL] [Abstract][Full Text] [Related]
23. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS.
Foroutan N; Fahimi F; Dabiri Y; Foroutan A; Habibi M; Salamzadeh J
J Popul Ther Clin Pharmacol; 2015 Dec; 22(3):e292-e302. PubMed ID: 28414416
[TBL] [Abstract][Full Text] [Related]
24. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit.
MacLaren R; Reynolds PM; Allen RR
JAMA Intern Med; 2014 Apr; 174(4):564-74. PubMed ID: 24535015
[TBL] [Abstract][Full Text] [Related]
25. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
[TBL] [Abstract][Full Text] [Related]
26. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
[TBL] [Abstract][Full Text] [Related]
27. Histamine 2 receptor antagonists vs intravenous proton pump inhibitors in a pediatric intensive care unit: a comparison of gastric pH.
Tofil NM; Benner KW; Fuller MP; Winkler MK
J Crit Care; 2008 Sep; 23(3):416-21. PubMed ID: 18725049
[TBL] [Abstract][Full Text] [Related]
28. Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis.
Alhazzani W; Guyatt G; Alshahrani M; Deane AM; Marshall JC; Hall R; Muscedere J; English SW; Lauzier F; Thabane L; Arabi YM; Karachi T; Rochwerg B; Finfer S; Daneman N; Alshamsi F; Zytaruk N; Heel-Ansdell D; Cook D;
Crit Care Med; 2017 Jul; 45(7):1121-1129. PubMed ID: 28459708
[TBL] [Abstract][Full Text] [Related]
29. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
Steinberg KP
Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
[TBL] [Abstract][Full Text] [Related]
30. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
Aoki T
J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
[TBL] [Abstract][Full Text] [Related]
31. Comparison of High Dose and Standard Dose Proton Pump Inhibitor before Endoscopy in Patients with Non-Portal Hypertension Bleeding.
Rattanasupar A; Sengmanee S
J Med Assoc Thai; 2016 Sep; 99(9):988-95. PubMed ID: 29927201
[TBL] [Abstract][Full Text] [Related]
32. [Risk factors of upper gastrointestinal complications in outpatients on antiplatelet therapy: description and management].
Ducrocq G; Bigard MA; Marouene S; Delaage PH; Fabry C; Barthelemy P; Steg PG;
Ann Cardiol Angeiol (Paris); 2012 Aug; 61(4):245-51. PubMed ID: 22579299
[TBL] [Abstract][Full Text] [Related]
33. [Antisecretory therapy strategy for patients with bleeding and perforated gastroduodenal ulcers].
Evseev MA; Ivakhov GB; Golovin RA
Khirurgiia (Mosk); 2009; (3):46-52. PubMed ID: 19391208
[No Abstract] [Full Text] [Related]
34. Pantoprazole for the prevention of gastrointestinal bleeding in high-risk patients with acute coronary syndromes.
Wu H; Jing Q; Wang J; Guo X
J Crit Care; 2011 Aug; 26(4):434.e1-6. PubMed ID: 21273036
[TBL] [Abstract][Full Text] [Related]
35. Esomeprazole compared with famotidine in the prevention of upper gastrointestinal bleeding in patients with acute coronary syndrome or myocardial infarction.
Ng FH; Tunggal P; Chu WM; Lam KF; Li A; Chan K; Lau YK; Kng C; Keung KK; Kwan A; Wong BC
Am J Gastroenterol; 2012 Mar; 107(3):389-96. PubMed ID: 22108447
[TBL] [Abstract][Full Text] [Related]
36. Effect of Stress Ulcer Prophylaxis With Proton Pump Inhibitors vs Histamine-2 Receptor Blockers on In-Hospital Mortality Among ICU Patients Receiving Invasive Mechanical Ventilation: The PEPTIC Randomized Clinical Trial.
; Young PJ; Bagshaw SM; Forbes AB; Nichol AD; Wright SE; Bailey M; Bellomo R; Beasley R; Brickell K; Eastwood GM; Gattas DJ; van Haren F; Litton E; Mackle DM; McArthur CJ; McGuinness SP; Mouncey PR; Navarra L; Opgenorth D; Pilcher D; Saxena MK; Webb SA; Wiley D; Rowan KM
JAMA; 2020 Feb; 323(7):616-626. PubMed ID: 31950977
[TBL] [Abstract][Full Text] [Related]
37. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
Geus WP; Lamers CB
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
[TBL] [Abstract][Full Text] [Related]
38. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
[TBL] [Abstract][Full Text] [Related]
39. Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial.
Taha AS; McCloskey C; Prasad R; Bezlyak V
Lancet; 2009 Jul; 374(9684):119-25. PubMed ID: 19577798
[TBL] [Abstract][Full Text] [Related]
40. Comparison of proton pump inhibitor and histamine-2 receptor antagonist in the prevention of recurrent peptic ulcers/erosions in long-term low-dose aspirin users: a retrospective cohort study.
Chen WC; Li YD; Chiang PH; Tsay FW; Chan HH; Tsai WL; Tsai TJ; Wang EM; Cheng JS; Lai KH
Biomed Res Int; 2014; 2014():693567. PubMed ID: 25295267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
